Clinical Trials Browser

Phase 2 × Peripheral Nervous System Diseases × Plasma cell × Clear all

NCT01783522 2019-10-22

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Phase 2 Terminated

9 enrolled 10 charts

Multiple Myeloma, Peripheral Nervous System Diseases

NCT00891618 2016-10-31

Acupuncture for Chemo-Induced Peripheral Neuropathy

Phase 2 Completed

27 enrolled 3 charts

LymphoidPlasma cell

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Peripheral Nervous System Diseases, Neoplasms, Plasma Cell

NCT02093910 2014-11-19

Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy

Phase 2 Unknown

Multiple Myeloma, Peripheral Nervous System Diseases